Company announces second-quarter financial results. (Immune response Corporation) (Information Briefs from Worldwide Sources)

DATELINE: Immune Response Corporation

The Immune Response Corporation reported a net loss of $927,000, or $.07 per share, for the second quarter of 1991 compared to net income of $233,000, or $.02 per share, recorded in the second quarter of 1990. Contract research revenue for the second quarter of 1991 was $1,087,000 vs. $1,041,000 in the same period in 1990. Interest income for the second quarter of 1991 increased to $703,000 from $514,000 in the second quarter of 1990.

For the six months ended June 30, 1991, contract revenues were $2,252,000 compared to $2,302,000 for the same period last year. The net loss of $2,944,000, or $.25 per share, for the …